FDA device chief defends US review process at govt hearing
This article was originally published in RAJ Devices
Executive Summary
US Food and Drug Administration device chief Jeffrey Shuren has admitted that the agency "could do a better job" at managing its pre-market review programmes, but has opposed suggestions that the US system be replaced with one similar to that in place in the EU1,2.